Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
261
335.4341
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Dr Sulaiman Al-Habib Medical Services Group Co stock under the Base Case scenario is 197.1 SAR. Compared to the current market price of 280 SAR, Dr Sulaiman Al-Habib Medical Services Group Co is Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dr Sulaiman Al-Habib Medical Services Group Co
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Dr Sulaiman Al-Habib Medical Services Group Co cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) has emerged as a beacon of healthcare excellence in the Middle East, rooted deeply in a commitment to enhancing patient care. Founded in 1995 by Dr. Sulaiman Al-Habib, the company has grown from a singular hospital in Riyadh to a sprawling network of advanced medical facilities across Saudi Arabia and the region. With a mission to deliver high-quality medical services, HMG operates multiple hospitals, clinics, and specialized centers, ensuring that a diverse array of healthcare needs—from routine check-ups to complex surgeries—are met with state-of-the-art technology and skilled practitioners. The company’s dedication to continuous impro...
Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) has emerged as a beacon of healthcare excellence in the Middle East, rooted deeply in a commitment to enhancing patient care. Founded in 1995 by Dr. Sulaiman Al-Habib, the company has grown from a singular hospital in Riyadh to a sprawling network of advanced medical facilities across Saudi Arabia and the region. With a mission to deliver high-quality medical services, HMG operates multiple hospitals, clinics, and specialized centers, ensuring that a diverse array of healthcare needs—from routine check-ups to complex surgeries—are met with state-of-the-art technology and skilled practitioners. The company’s dedication to continuous improvement is evident in its robust investment in research and development, alongside strategic partnerships that enhance its medical offerings.
For investors, HMG represents a compelling opportunity within the booming healthcare sector. As the demand for quality medical services rises—fueled by a growing population and a heightened focus on health—HMG's established reputation and expansive market presence position it favorably for continued growth. The group's financial stability, underpinned by innovative healthcare solutions and a strong brand, highlights its potential for profitability in the years to come. With a vision to lead in integrated healthcare services, Dr. Sulaiman Al-Habib Medical Services Group Co. not only stands out for its operational excellence but also offers investors the chance to be part of a transformative journey in the healthcare landscape of the Middle East.
Dr. Sulaiman Al-Habib Medical Services Group Co. is one of the leading healthcare providers in Saudi Arabia and the Middle East. The core business segments of the company typically include:
-
Hospital Operations: The company operates multiple hospitals that provide a wide range of medical and surgical services. These facilities are usually equipped with advanced medical technology and staffed by qualified healthcare professionals.
-
Outpatient Clinics: In addition to hospitals, the group offers outpatient services through a network of clinics that provide primary care and specialized medical services to patients without the need for overnight hospitalization.
-
Pharmaceuticals and Medications: The medical group often has an integrated pharmacy service, making a range of medications and health products available to patients both in hospitals and clinics.
-
Diagnostic Services: This segment includes laboratories and imaging centers that offer diagnostic testing and imaging services (e.g., MRI, CT scans, etc.) as part of the healthcare continuum.
-
Health Insurance Services: Dr. Sulaiman Al-Habib Medical Services Group may also provide health insurance products or collaborate with insurance providers to offer plans that cover treatments within their facilities.
-
Telehealth Services: With the growing trend towards digital health, the group may offer telehealth services that facilitate remote consultations and follow-ups, enhancing patient access to healthcare.
-
Specialty Medical Services: These include specialized departments in areas such as cardiology, orthopedics, oncology, and pediatrics, catering to specific patient needs.
-
Education and Training: The organization may have a focus on training and developing medical professionals, contributing to the growth and improvement of healthcare quality in the region.
-
Research and Development: Engaging in medical research to innovate and improve healthcare delivery and treatment options could also be a segment of focus for the company.
These segments collectively contribute to the overarching mission of Dr. Sulaiman Al-Habib Medical Services Group in delivering quality healthcare services while striving for operational excellence and patient satisfaction.
Dr. Sulaiman Al-Habib Medical Services Group Co (HMG) stands out in the healthcare sector due to several unique competitive advantages:
-
Comprehensive Healthcare Services: HMG offers a wide range of services including hospitals, outpatient clinics, pharmacies, and laboratories. This one-stop-shop approach enhances patient convenience and consolidates the company's presence in the healthcare market.
-
Strong Brand Reputation: The group has established a solid reputation for medical excellence and quality patient care. Trust is a critical factor in healthcare, and a strong brand can attract more patients.
-
Advanced Medical Technology: HMG consistently invests in the latest medical technologies and equipment. This commitment to innovation enhances the quality of care and enables more effective treatments.
-
Highly Qualified Medical Staff: The group employs top-tier medical professionals and specialists, ensuring high standards of care. An experienced workforce can significantly improve patient outcomes and satisfaction.
-
Strategic Alliances and Partnerships: HMG has formed partnerships with various healthcare organizations and academic institutions, facilitating collaborative research, access to cutting-edge treatments, and improved service offerings.
-
Robust Financial Position: With a strong balance sheet and consistent revenue growth, HMG can invest in expansion, technology, and talent, creating a barrier to entry for potential competitors.
-
Focus on Patient Experience: HMG prioritizes patient-centric services, focusing on delivering superior customer service, which can lead to higher patient retention rates and referrals.
-
Geographic Presence: HMG has a significant presence in key markets, especially in the Gulf Cooperation Council (GCC) region, providing them with advantage in market share and accessibility.
-
Regulatory Compliance: Maintaining robust compliance with healthcare regulations enhances HMG's credibility and operational sustainability, crucial in a heavily regulated industry.
-
Research and Development: Continuous investment in R&D helps the group stay ahead of medical trends and innovations, allowing it to offer new treatment options that competitors may not provide.
These advantages contribute to a solid competitive position in the healthcare industry, allowing Dr. Sulaiman Al-Habib Medical Services Group Co to continue growing and succeeding against its rivals.
Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) may face several risks and challenges in the near future, which can be categorized into various domains:
1. Industry and Market Risks
- Regulatory Changes: Changes in healthcare regulations or government policies in Saudi Arabia could impact operational costs and compliance requirements.
- Market Competition: Increased competition from other healthcare providers and emerging private hospitals may affect market share and pricing strategies.
- Economic Fluctuations: Economic instability can influence consumer spending patterns on healthcare services, impacting revenue.
2. Operational Risks
- Quality of Care: Maintaining high standards of patient care amidst growing patient volumes can be challenging and could lead to reputational risks if not managed properly.
- Supply Chain Disruptions: Global supply chain issues could lead to shortages of medical supplies and equipment, affecting service delivery.
- Technological Advancements: Failing to keep up with technological changes in healthcare delivery and patient management systems can hinder operational efficiency.
3. Financial Risks
- Funding and Capital Access: Changes in financial markets could impact access to capital for expansions or innovations in medical services.
- Insurance Dependencies: Reliance on third-party payers and insurance companies can lead to cash flow challenges if reimbursements are delayed or reduced.
4. Human Resource Challenges
- Talent Acquisition and Retention: Difficulty in recruiting and retaining qualified healthcare professionals can affect service quality and operational efficiency.
- Training and Development: Ongoing training is essential to keep staff updated on new technologies and practices; failure to invest in this area may lead to service shortcomings.
5. Reputation and Brand Risks
- Patient Experience: Negative patient experiences can swiftly damage reputation and trust, especially with social media as a powerful platform for sharing feedback.
- Data Security: Increasing instances of cyberattacks can threaten the security of patient data and operational integrity, leading to reputational and financial damages.
6. Technological Disruptions
- Telemedicine Trends: With the rise in telemedicine, traditional healthcare models may face obsolescence if not integrated and adapted appropriately.
- Data Management: The growing need for electronic health records and data analytics poses challenges in terms of compliance and data security.
7. Pandemic and Health Crisis Management
- Future Health Crises: The emergence of new health crises, similar to COVID-19, can strain resources and operational capabilities.
Mitigation Strategies
To address these risks, HMG can adopt strategies such as diversifying service offerings, investing in technology, enhancing staff training programs, focusing on patient engagement and experience, and developing robust crisis management plans. Additionally, closely monitoring regulatory and economic environments can help in proactive decision-making.
Revenue & Expenses Breakdown
Dr Sulaiman Al-Habib Medical Services Group Co
Balance Sheet Decomposition
Dr Sulaiman Al-Habib Medical Services Group Co
Current Assets | 3.8B |
Cash & Short-Term Investments | 1.3B |
Receivables | 1.2B |
Other Current Assets | 1.2B |
Non-Current Assets | 13.6B |
Long-Term Investments | 498.4m |
PP&E | 13.1B |
Other Non-Current Assets | -10 |
Current Liabilities | 3.7B |
Accounts Payable | 1.7B |
Accrued Liabilities | 1.8B |
Other Current Liabilities | 226.3m |
Non-Current Liabilities | 6.9B |
Long-Term Debt | 5.8B |
Other Non-Current Liabilities | 1B |
Earnings Waterfall
Dr Sulaiman Al-Habib Medical Services Group Co
Revenue
|
10B
SAR
|
Cost of Revenue
|
-6.6B
SAR
|
Gross Profit
|
3.5B
SAR
|
Operating Expenses
|
-1.3B
SAR
|
Operating Income
|
2.2B
SAR
|
Other Expenses
|
-18.3m
SAR
|
Net Income
|
2.2B
SAR
|
Free Cash Flow Analysis
Dr Sulaiman Al-Habib Medical Services Group Co
SAR | |
Free Cash Flow | SAR |
Profitability Score
Profitability Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dr Sulaiman Al-Habib Medical Services Group Co
According to Wall Street analysts, the average 1-year price target for Dr Sulaiman Al-Habib Medical Services Group Co is 305.26 SAR with a low forecast of 247.45 SAR and a high forecast of 346.5 SAR.
Dividends
Current shareholder yield for Dr Sulaiman Al-Habib Medical Services Group Co is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2020-02-26. The firm operates through it's subsidiaries in three segments: Hospitals, Pharmacies and Other. The Hospital segment is engaged in setting up, managing and operating hospitals, medical facilities, pharmacies and medical diagnostic and radiological laboratories. The Pharmacies segment operates Al Habib Pharmacies, Middle East Pharmacies Company and Afia Pharmacies Company. The Other segments include management and operations services for third party, home healthcare service, intensive care units, ambulatory transportation, facility maintenance services information technology and systems services, cloud solutions, among others. The firm also provides import and export, wholesale and retail sale of medicines, medical and herbal products, cosmetics, medical devices and equipment.
Officers
The intrinsic value of one Dr Sulaiman Al-Habib Medical Services Group Co stock under the Base Case scenario is 197.1 SAR.
Compared to the current market price of 280 SAR, Dr Sulaiman Al-Habib Medical Services Group Co is Overvalued by 30%.